On the afternoon of September 19, 2017, the first Shenzhen Youth Entrepreneurship Person of the Year Selection and the 'Creating Youth' Shenzhen Youth Innovation and Entrepreneurship Competition Award Ceremony came to a successful conclusion.
A total of 375 project teams signed up for this competition, covering mobile Internet, new energy and energy conservation and environmental protection, biology and life technology, new manufacturing and other areas.
After numerous competitions, 6 winning projects were finally selected. feellife medical won the first prize: providing a third way of drug delivery for humans.
Hua Jian, founder of feellife Medical, receives the award
Hua Jian, founder of feellife Medical, receives the award
Hua Jian, founder of feellife Medical, was interviewed by Shenzhen Satellite TV media
First Prize Trophy of 'Creating Youth' Competition
Since its establishment, feellife Medical has been focusing on the development and production of medical home nebulizers with the vision of 'providing a third way of drug delivery for human beings'. This vision and original intention are in line with the trend of medical development, and this award is also the recognition and encouragement of the society for feellife medical.
For respiratory diseases, the well-known injections and medicines are the traditional methods of administration, and they are also the treatment methods that have lasted for several years in the hospital. However, research shows that taking medicine and injections is not what most people want, especially children.
It is precisely because of the effectiveness and small side effects of atomization therapy that most hospitals in China have established special atomization rooms. In addition to the side effects of injections and infusions, the country is gradually implementing the prohibition of antibiotic infusions, and explicitly lists 53 diseases that do not require infusions.
Internationally, WHO has listed aerosol inhalation as one of the safest and most effective methods for the treatment of pneumonia, acute and chronic bronchitis, and asthma.
With the development of science and technology, atomizers are also becoming more intelligent, miniaturized and portable. The usage scenarios are not limited to hospitals, but are more used in homes, offices and other places. Especially families with children and the elderly are more willing to choose this method to relieve respiratory diseases. In the future, like mobile phones, it may become a standard electronic product in the family.
In the medical device industry, the closed-loop R&D industry chain of enterprises is rarely seen, but feellife medical is such a company.
R&D, production and sales are integrated, and its own original atomization research institute is engaged in the research of atomization micro-grid technology. It has production plants in Los Angeles, Shenzhen Songgang, Huangtian and Huizhou in the United States.
Concentrating on the research and development of more than a dozen patented technologies, the 'two titanium and one core' technology (titanium alloy atomized sheet, lithium titanate battery, American Microchip chip) is beyond the reach of other companies. As many as 30 quality inspections ensure that each factory product is up to standard. It is this kind of solid strength that makes today's strong feellife.
Los Angeles factory
'Providing a third way of drug delivery for human beings' is the core vision of feellife medical. In the future, its hope is to make atomization inhalation therapy enter a more scientific and quantitative level, establish an atomization ecosystem, and make atomization treatment possible. Methods have become the mainstream way of human treatment of various diseases.
feellife medical, provides a third way of drug delivery for human beings, in the future, make persistent efforts! ! !